Clinical trial Recruiting at 1 site Observational Ages Any age to 100

Using ultrasound and AI to diagnose sarcopenia in older adults

Official title: An Artificial Intelligence Assessment System for Risk Grading of Sarcopenia Based on Ultrasonographic Multidimensional Data

Run by West China Hospital · NCT06199856 · Data updated 2026-11-12

This study is testing if using ultrasound and artificial intelligence can help doctors better diagnose muscle loss in older adults to improve their health and quality of life.

More Ultrasound trials

Quick facts

Study typeObservational
AgesAny age to 100 Years
SexAll
Enrollment1500 (estimated)
SponsorWest China Hospital
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedOctober 1, 2020
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedMarch 14, 2025
Trial IDNCT06199856 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals over 50 years of age who exhibit signs of suspected sarcopenia.

Probably not a fit

Patients with amputations, severe edema, or other significant health issues that prevent participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop an artificial intelligence-assisted diagnostic model for sarcopenia using ultrasound images. It focuses on creating classification and regression models that can aid in diagnosing sarcopenia, estimating patient strength, and performing other related functions based on ultrasound data. Sarcopenia is a significant concern for older adults, as it involves the loss of muscle mass and function, which can worsen the prognosis of various diseases. By identifying sarcopenia early, the study seeks to improve the quality of life for older individuals.

Why it matters

Potential benefit: If successful, this approach could lead to earlier and more accurate diagnoses of sarcopenia, allowing for timely interventions that enhance patient quality of life.

How similar studies have gone: While the use of ultrasound in diagnosing sarcopenia is gaining interest, this specific AI-assisted approach is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \> 50 years of age
* Patients with suspected sarcopenia, for example, who needed assistance with walking, rising from a chair, or climbing stairs; recently had a history of falls walking; recent unintentional weight loss

Exclusion Criteria:

* Amputated arm or leg
* Severe oedema (oedema higher than knee level)
* Implantable pacemaker
* Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study

Where it's running

  • Xinyi Tang
    Chengdu, Sichuan, China
    Recruiting

Study contacts

  • Principal investigator: Xinyi Tang, Dr. — Department of Medical Ultrasound, West China Hospital, Sichuan University
  • Study coordinator: Xinyi Tang, Dr.
  • Email: tangxinyi1996@outlook.com
  • Phone: +8615680819215

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.